We showed that TMG significantly elevates LC3 protein levels in SY5Y cells and human brain organoids differentiated from normal individuals, while TMG failed to increase LC3 in organoids derived from AD patients. This evidence concerns the gene MAP1LC3A and Alzheimer disease.